If the patient enrolled in a commercial weight-loss program (Weight Watchers, Noom, Jenny Craig, or a hospital-based program), the provider must submit: Enrollment confirmation with start date Attendance or participation logs showing at least 90 days of engagement Documentation that the program did not result in sustained weight loss (defined as less than 5% body weight reduction) Option 3: Bariatric counseling visit notes
There are a few things that are important to note
Absolute Contraindications Both semaglutide and tirzepatide carry a boxed warning for thyroid C-cell tumors based on rodent carcinogenicity studies [6][7]
For example, there may be differences in the sets of complications that are captured [59]
This is an important therapeutic goal because the risk of sarcopenic obesity increases with aging and is associated with worse glucose and blood pressure control, higher insulin resistance, higher prevalence of dyslipidemia, T2D, cardiovascular diseases, NAFLD, and higher mortality than sarcopenia or obesity alone (54, 55)
Additionally, try avoiding foods and substances that may exacerbate symptoms